• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Renal clearance and tissue accumulation of gentamicin.

作者信息

Schentag J J, Jusko W J

出版信息

Clin Pharmacol Ther. 1977 Sep;22(3):364-70. doi: 10.1002/cpt1977223364.

DOI:10.1002/cpt1977223364
PMID:330081
Abstract

Multiple-dose studies of gentamicin pharmacokinetics were performed in 2 treated patients. After the final dose, serum and urine concentration declined in biphasic fashion with beta half-lives of 87 and 173 hr. Recovery of the total dose administered required urine collection for at least 10 to 20 days after the last dose. A two-compartment model was used to describe the biphasic decline in serum concentrations, to simulate all measured concentrations during treatment, and to predict the amount of gentamicin in the tissue compartment. Analysis of autopsy tissues yielded the predicted amount of drug. A linear two-compartment model adequately quantitates gentamicin disposition until about 4 days after cessation of therapy when gentamicin renal clearance begins to decline because of tubular reabsorption.

摘要

相似文献

1
Renal clearance and tissue accumulation of gentamicin.
Clin Pharmacol Ther. 1977 Sep;22(3):364-70. doi: 10.1002/cpt1977223364.
2
Tissue persistence of gentamicin in man.
JAMA. 1977 Jul 25;238(4):327-9.
3
A model for dosing gentamicin in children and adolescents that adjusts for tissue accumulation with continuous dosing.一种针对儿童和青少年的庆大霉素给药模型,该模型通过持续给药来调整组织蓄积情况。
Clin Pharmacokinet. 1980 May-Jun;5(3):295-306. doi: 10.2165/00003088-198005030-00007.
4
Gentamicin tissue accumulation and nephrotoxic reactions.庆大霉素的组织蓄积及肾毒性反应。
JAMA. 1978 Nov 3;240(19):2067-9.
5
Dosing implications of altered gentamicin disposition in patients with cystic fibrosis.
J Pediatr. 1982 Feb;100(2):312-8. doi: 10.1016/s0022-3476(82)80663-x.
6
Pharmacokinetics and tissue residues of gentamicin in lactating cows after multiple intramuscular doses are administered.多次肌肉注射给药后,庆大霉素在泌乳奶牛体内的药代动力学及组织残留情况。
Am J Vet Res. 1987 Jan;48(1):21-7.
7
Prediction of gentamicin serum levels using a one-compartment open linear pharmacokinetic model.
Am J Hosp Pharm. 1978 Sep;35(9):1078-81.
8
Longstanding post-therapeutic gentamicin serum and urine concentrations in patients with unimpaired renal function. A pharmacokinetic evaluation.肾功能正常患者治疗后庆大霉素的长期血清和尿液浓度。一项药代动力学评估。
J Antimicrob Chemother. 1978 Mar;4(2):143-52. doi: 10.1093/jac/4.2.143.
9
Gentamicin-PMMA beads. Pharmacokinetic and nephrotoxicological study.庆大霉素-聚甲基丙烯酸甲酯珠。药代动力学和肾毒理学研究。
Clin Orthop Relat Res. 1986 Apr(205):171-83.
10
Amikacin and gentamicin accumulation pharmacokinetics and nephrotoxicity in critically ill patients.阿米卡星和庆大霉素在危重症患者中的蓄积药代动力学及肾毒性
Antimicrob Agents Chemother. 1981 Jan;19(1):147-52. doi: 10.1128/AAC.19.1.147.

引用本文的文献

1
Pharmacokinetic modelling to predict risk of ototoxicity with intravenous tobramycin treatment in cystic fibrosis.药代动力学模型预测静脉注射妥布霉素治疗囊性纤维化患者耳毒性的风险。
J Antimicrob Chemother. 2021 Oct 11;76(11):2923-2931. doi: 10.1093/jac/dkab288.
2
Drug disposition model of radiolabeled etelcalcetide in patients with chronic kidney disease and secondary hyperparathyroidism on hemodialysis.放射性标记依特卡肽在慢性肾脏病和继发性甲状旁腺功能亢进血液透析患者中的药物处置模型
J Pharmacokinet Pharmacodyn. 2017 Feb;44(1):43-53. doi: 10.1007/s10928-016-9503-z. Epub 2017 Jan 6.
3
Development and Evaluation of a Gentamicin Pharmacokinetic Model That Facilitates Opportunistic Gentamicin Therapeutic Drug Monitoring in Neonates and Infants.
促进新生儿和婴儿机会性庆大霉素治疗药物监测的庆大霉素药代动力学模型的开发与评估。
Antimicrob Agents Chemother. 2016 Jul 22;60(8):4869-77. doi: 10.1128/AAC.00577-16. Print 2016 Aug.
4
Population pharmacokinetic study of gentamicin in a large cohort of premature and term neonates.庆大霉素在大量早产和足月新生儿队列中的群体药代动力学研究。
Br J Clin Pharmacol. 2014 Nov;78(5):1090-101. doi: 10.1111/bcp.12444.
5
Developmental pharmacokinetics of gentamicin in preterm and term neonates: population modelling of a prospective study.庆大霉素在早产儿和足月儿中的发育药代动力学:一项前瞻性研究的群体建模
Clin Pharmacokinet. 2009;48(4):253-63. doi: 10.2165/00003088-200948040-00003.
6
Target concentration intervention is needed for tobramycin dosing in paediatric patients with cystic fibrosis--a population pharmacokinetic study.囊性纤维化患儿使用妥布霉素给药需要进行目标浓度干预——一项群体药代动力学研究。
Br J Clin Pharmacol. 2008 Apr;65(4):502-10. doi: 10.1111/j.1365-2125.2007.03045.x. Epub 2007 Nov 8.
7
Quantitative justification for target concentration intervention--parameter variability and predictive performance using population pharmacokinetic models for aminoglycosides.目标浓度干预的定量论证——使用氨基糖苷类药物群体药代动力学模型的参数变异性和预测性能
Br J Clin Pharmacol. 2004 Jul;58(1):8-19. doi: 10.1111/j.1365-2125.2004.02114.x.
8
Aminoglycoside dosages and nephrotoxicity: quantitative relationships.氨基糖苷类药物剂量与肾毒性:定量关系
Clin Pharmacokinet. 2003;42(5):493-500. doi: 10.2165/00003088-200342050-00007.
9
Aminoglycoside nephrotoxicity: modeling, simulation, and control.氨基糖苷类药物肾毒性:建模、模拟与控制
Antimicrob Agents Chemother. 2003 Mar;47(3):1010-6. doi: 10.1128/AAC.47.3.1010-1016.2003.
10
Influence of dose on the disposition kinetics of netilmicin in the isolated kidney of the rat.剂量对奈替米星在大鼠离体肾脏中处置动力学的影响。
Eur J Drug Metab Pharmacokinet. 2002 Apr-Jun;27(2):127-33. doi: 10.1007/BF03190427.